Sylvester Comprehensive Cancer Center shared on LinkedIn:
“New research from our experts is uncovering a potential way to overcome treatment resistance in advanced prostate cancer.
In a study published in Cancer Research, Sylvester researchers, including Dr. Kerry Burnstein, investigated why some advanced prostate cancers continue to progress after becoming resistant to hormone therapy.
Their findings uncovered a potential new strategy for making treatment – resistant prostate cancer more responsive to existing therapies and slowing tumor growth in preclinical models.